The Canadian semaglutide market is estimated to be over $1.5 billion, and analysts expect Dr. Reddy’s to benefit from a limited competition window of about six to nine months.
The Canadian semaglutide market is estimated to be over $1.5 billion, and analysts expect Dr. Reddy’s to benefit from a limited competition window of about six to nine months.